Toxicity and tolerability of adjuvant breast cancer chemotherapy in obese women.

@article{Carroll2014ToxicityAT,
  title={Toxicity and tolerability of adjuvant breast cancer chemotherapy in obese women.},
  author={James Carroll and Melinda M. Protani and Linda N Nguyen and Matthew E Cheng and Mike Fay and Mohamed Saleem and Praga S Pillay and Euan Thomas Walpole and Jennifer H Martin},
  journal={Medical oncology},
  year={2014},
  volume={31 4},
  pages={
          881
        }
}
The purpose of this study was to compare toxicity rates and types between obese and non-obese women during adjuvant chemotherapy for breast cancer, adjusting for regimen type and received dose. We conducted a retrospective cohort study of 537 women receiving chemotherapy, initially treated between 2007 and 2010 at two tertiary hospitals in Brisbane, Australia. Demographic, chemotherapy and toxicity data were extracted from patient charts and analyzed using multivariate logistic regression… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-5 of 5 citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Use of non-anthracycline regimens in early stage breast cancer in Australia

  • RH De Boer, A Chan, B Tran, N. Wilcken
  • Asia Pacific J Clin Oncol. ;7(1):4–10
  • 2010
Highly Influential
4 Excerpts